Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data AURORA CANNABIS INC files with the SEC in its annual reports.
In CAD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Revenue
55.2
246
269
245
221
270
343
Gross profit
43.5
142
-19.9
-21.6
21.2
132
188
Research and development
1.68
14.8
26
11.4
10.4
3.57
3.68
Selling, general and administrative
175
175
144
Operating income
-95.8
-318
-466
-283
-231
-45.1
4.95
Interest expense
11.8
39.4
76.1
66.4
71.8
13.8
8.42
Pre-tax income
77.3
-331
-3,340
-700
-1,720
-57.6
20.4
Income tax
8.1
-29.9
-82.2
-6.32
-2.14
-0.55
4.62
Income from continuing operations
-301
-3,257
-693
-1,718
-57.1
15.8
Net income to minority interests
-2.71
-7.09
-1.46
-0.36
Net income
71.9
-294
-3,283
-692
-1,718
-69.3
1.59
EBITDA
-83.7
-255
-398
-234
-183
-33.1
14
EPS, basic
0.16
-0.29
-33.93
-4.10
-7.99
-1.52
0.04
EPS, diluted
0.15
-0.29
-33.93
-4.10
-7.99
-1.52
0.04
Balance sheet
FY2019
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Cash and equivalents
76.8
173
162
421
438
136
138
Short-term investments
4.04
0.55
Receivables
15.1
103
54.1
56.3
47
45.4
42.5
Inventory
29.6
111
136
117
116
144
188
Total current assets
220
661
418
666
745
427
478
Property, plant and equipment
246
766
946
606
233
264
Lease right-of-use assets
30.7
Goodwill
761
3,173
928
888
0
43.2
43.9
Intangible assets
200
688
412
367
70.7
40.9
45.2
Total assets
1,887
5,499
2,780
2,605
1,084
839
853
Accounts payable
47.5
153
95.6
57.9
69.9
58.6
73.6
Short-term debt
0
52.4
21.5
Total current liabilities
75.2
436
272
116
131
125
111
Lease liabilities
83.7
65.4
36.8
42.7
37.5
Total liabilities
334
1,112
657
567
422
237
244
Total debt
11.7
141
204
0
38.2
42.5
Retained earnings
87.7
-286
-3,596
-4,321
-6,035
-6,368
-6,368
Shareholders' equity
1,548
4,383
2,148
2,038
662
560
567
Minority interests
4.56
4.41
-24.4
0
0.51
42.1
41.4
Total equity
1,553
4,383
2,123
2,038
666
602
609
Total liabilities and equity
1,887
5,499
2,780
2,605
1,084
839
853
Cash flow statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Net income
69.2
-301
-3,309
-695
-1,718
-69.3
1.59
Depreciation and amortization
12.1
63.3
67.6
49.2
48.6
12
9.08
Cash from operations
-81.7
-192
-342
-211
-110
-68.5
16
Capital expenditures
-137
-414
-53.1
-32.2
Cash from investing
-537
-312
-245
-26.9
-36.2
-3.36
-14.3
Debt repaid
0
-3.04
-7.25
Stock issued
216
59.3
576
666
350
37.9
0
Cash from financing
535
598
583
522
148
-47.9
-0.12
Exchange rate effect
0.36
2.94
-5.54
-25.2
15
0.3
0.26
Net change in cash
-83
95.9
-10.5
259
16.4
-119
1.83
Free cash flow
-219
-607
-264
-142
Interest paid
18.1
47.9
34.2
27.7
14.9
6.84
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Gross margin
54.6%
Gross profit / revenue.
Operating margin
1.4%
Operating income / revenue.
EBITDA margin
4.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
5.9%
Pre-tax income / revenue.
Net margin
0.5%
Net income / revenue.
Operating cash flow margin
4.7%
Cash from operations / revenue.
Effective tax rate
22.7%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
0.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
0.2%
Net income / average total assets.
Return on invested capital (ROIC)
0.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
1.1%
Research and development expense / revenue.
D&A / revenue
2.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
27.3%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
42.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
1.3%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
1.7%
Total assets vs the same period a year earlier. Only from a positive base.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
4.31x
Current assets / current liabilities.
Quick ratio
1.63x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.25x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.07x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
5.0%
Total debt / total assets.
Liabilities / assets
28.6%
Total liabilities / total assets.
Net debt
-CA$96.0M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
-6.84x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
CA$0.04
Net income per basic share, as reported (split-adjusted).
What was AURORA CANNABIS INC's revenue in fiscal 2025?
AURORA CANNABIS INC reported revenue of CA$343.3M for fiscal 2025, 27.3% higher than the year before.
Was AURORA CANNABIS INC profitable in fiscal 2025?
Yes. Net income was CA$1.6M, a net margin of 0.5%.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.